港股異動 | 黃金股走強 招金礦業(1818.HK)續升4%兩日大漲超18%
格隆匯9月15日丨黃金股延續上漲行情,港股招金礦業續漲近4%,兩日大漲超18%;山東黃金、紫金礦業、中國黃金國際均上漲。A股赤峯黃金、中金黃金、山東黃金均漲超1%。COMEX 12月黃金期貨昨日收漲0.8%,創下本月最大單日漲幅,並創下了自本月初以來的最高收盤價,原因是美元匯率和美國國債收益率雙雙下跌。世界黃金協會日前指出,關於新冠病毒對全球經濟的真正影響,仍然面臨許多不確定性。另外,還有其他尚未真正解決的風險,例如英國脱歐。而大多數發達市場的實際利率為負,這增加了黃金作為無息資產的吸引力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.